Trial intelligence / Profile preview

Binaural beat music and esketamine for postpartum neuropsychiatric outcomes after cesarean section

ChiCTR2400080184Phase 4Recruiting

Sponsor
First Affiliated Hospital of Chongqing Medical University
Start
Jan 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of esketamine in postpartum depression (PPD) and mental disorder (8 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoint: Postpartum depression incidence assessed by Edinburgh Postnatal Depression Scale. Started Jan 2024; status: recruiting.

02

Drugs

esketamine
03

Conditions

postpartum depression (PPD)mental disorder

Beyond the preview

Go deeper on ChiCTR2400080184.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400080184.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call